Trial Details
Not recruitingBasic Information
| Clinical ID | c2972 |
|---|---|
| Identifier | NCT02625259 |
| Trial Title | A Phase 1, Open-Label Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric pH Modification on the Pharmacokinetics of MLN1117 in Healthy Subjects |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Neoplasm, Advanced or Metastatic |
| Interventions | Drug: MLN1117;Drug: Lansoprazole;Drug: MLN1117 |
Participant Information
| Sponsor | Millennium Pharmaceuticals, Inc. |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |